Erasca
ERAS
109 hedge funds and large institutions have $140M invested in Erasca in 2023 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 48 increasing their positions, 29 reducing their positions, and 12 closing their positions.
200% more call options, than puts
Call options by funds: $3K | Put options by funds: $1K
66% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 29
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
2.11% less ownership
Funds ownership: 49.31% → 47.19% (-2.1%)
3% less funds holding
Funds holding: 112 → 109 (-3)
25% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 12
32% less capital invested
Capital invested by funds: $205M → $140M (-$64.8M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$1.28M |
| 2 |
IBT
International Biotechnology Trust
London,
United Kingdom
|
+$1.28M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$1.19M |
| 4 |
SMH
Sanders Morris Harris
Houston,
Texas
|
+$1.09M |
| 5 |
HF
HRT Financial
New York
|
+$384K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.86M |
| 2 |
PM
Prosight Management
Dallas,
Texas
|
-$3.31M |
| 3 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$2.22M |
| 4 |
Millennium Management
New York
|
-$1.98M |
| 5 |
Renaissance Technologies
New York
|
-$1.05M |
ERAS Hedge Fund Activity: Q3 2023 in Review
109 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Erasca (ERAS) for Q3 2023, worth a combined $140M — down 32% from $205M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of ERAS and 9 opened new positions — a net loss of 3 holders — while 29 trimmed existing stakes and 48 added.
The largest buyer was Armistice Capital, adding an estimated $1.28M. The largest seller was Vanguard Group, cutting an estimated $3.86M.
- 109 institutional investors held Erasca (ERAS) as of Q3 2023, down from 112 in Q2 2023.
- Funds reported $140M of Erasca stock for Q3 2023, down 32% quarter-over-quarter.
- 9 funds opened new Erasca positions in Q3 2023 and 12 closed out, a net change of -3 holders.
- The largest Erasca buyer in Q3 2023 was Armistice Capital, an estimated $1.28M added.
- The largest Erasca seller in Q3 2023 was Vanguard Group, an estimated $3.86M sold.
Based on aggregated 13F filings for Q3 2023.